Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
93.44
+0.87 (0.94%)
At close: Nov 2, 2026, 4:00 PM EST
93.46
+0.02 (0.02%)
After-hours: Nov 2, 2026, 7:32 PM EST
Rhythm Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Maintains $143 | Buy | Maintains | $143 | +53.04% | Oct 28, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $143 | Buy | Reiterates | $143 | +53.04% | Oct 19, 2026 |
| William Blair | William Blair | Buy Initiates $206 | Buy | Initiates | $206 | +120.46% | Oct 16, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $146 → $145 | Buy | Reiterates | $146 → $145 | +55.18% | Oct 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $105 → $130 | Buy | Reiterates | $105 → $130 | +39.13% | Oct 12, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Oct 9, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $155 → $159 | Buy | Reiterates | $155 → $159 | +70.16% | Oct 8, 2026 |
| Wolfe Research | Wolfe Research | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Sep 17, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.